Title {1}	0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate Solution in children admitted to PICU – a randomised controlled trial – SPLYT-P
Trial registration {2a and 2b}.	The trial is registered in the Australian New Zealand Clinical Trials Registry (ACTRN12619001244190).
Protocol version {3}	Protocol Version 6, dated 29/07/2020
Funding {4}	The study was supported by a grant from the Study, Education and Research Trust Account funding scheme 2019, Children’s Health Queensland, Brisbane, Australia. The funding sources had no involvement in study design, analyses, nor interpretation of the results.
Author details {5a}	1. Dr Sainath Raman1,2, MRCPCH, PhD, FCICM 2. Prof. Dr. Andreas Schibler1,2, MD, FCICM 3. Renate Le Marsney1, BMedSc, MPH 4. Assoc. Prof. Dr. Peter Trnka3, MD, FRACP, MSc 5. Melanie Kennedy1,2, BNursing 6. Assoc. Prof. Dr. Adrian Mattke1,2 MBBS, MD, FRACP, FCICM 7. Assoc. Prof. Dr. Kristen Gibbons1, BInfoTech, BMaths (Hons), PhD 8. Assoc. Prof. Dr. Luregn J Schlapbach1,4, MD, PhD, FCICM Affiliations: 1. Paediatric Critical Care Research Group, Child Health Research Centre, The University of Queensland, Queensland, Australia 2. Paediatric Intensive Care Unit, Queensland Children’s Hospital, South Brisbane, Australia. 3. Paediatric Nephrology, Queensland Children’s Hospital, South Brisbane, Australia 4. Pediatric and Neonatal Intensive Care Unit, Children’s Research Center, University Children's Hospital Zurich, Zurich, Switzerland
Name and contact information for the trial sponsor {5b}	Ms. Sabine Sand Research Partnership manager Faculty of Medicine The University of Queensland, 288 Herston Rd, Herston, Qld 4006 Australia. email: med.rpms@uq.edu.au
Role of sponsor {5c}	The sponsor (The University of Queensland) and the funding body (Children’s Health Queensland) had no involvement in study design, analyses, nor interpretation of the results.